Contrave vs. GLP-1 Injections for Weight Loss: Effectiveness, Cost, and Side Effects

Contrave targets emotional eating through the brain's reward system. GLP-1 medications target physical hunger. At 5–6% vs 15–22% average weight loss, the effectiveness gap is large — but Contrave has a niche that GLP-1s don't fill.

Contrave occupies a unique position in the weight loss medication landscape. It doesn't suppress appetite through gut hormones or stimulant effects. Instead, it targets the reward circuitry that drives overeating in response to stress, boredom, and emotional triggers.

For some patients, that matters more than raw weight loss numbers.

Different Drugs, Different Problems

The core insight about Contrave vs. GLP-1 medications is that they address fundamentally different types of overeating.

GLP-1 medications are ideal when the primary driver is physical hunger — your body sends too many hunger signals, gastric emptying is too fast, or your satiety hormones aren't working properly. The medication fixes the signaling, and appetite normalizes.

Contrave is better when the driver is reward-seeking behavior — eating when you're not physically hungry, food cravings triggered by stress or emotion, the "one more bite" compulsion, and the pleasure-driven overconsumption that has nothing to do with actual hunger. Naltrexone blocks the opioid-receptor response that makes food feel rewarding, while bupropion reduces cravings and mildly suppresses appetite.

Many patients have both physical and psychological drivers, which is why some providers are now combining low-dose Contrave with GLP-1 medications — targeting both pathways simultaneously.

Effectiveness: Honest Numbers

On pure weight loss numbers, GLP-1s dominate. But Contrave has two advantages the numbers don't capture: it directly treats the reward-seeking behavior that many patients identify as their core challenge, and the bupropion component can simultaneously improve depression — a condition that drives overeating in millions of patients.

Side Effects: Different Profiles

Contrave's side effects are neurological rather than gastrointestinal. The most common are nausea (32.5%), constipation (19.2%), headache (17.6%), and insomnia (9.2%). Nausea is typically worst during the first 4 weeks and improves.

The black box warning deserves attention: Bupropion carries an FDA black box warning for suicidal thoughts and behaviors, particularly in young adults under 25. This doesn't mean Contrave causes suicidality — bupropion is one of the most commonly prescribed antidepressants globally — but monitoring is essential, especially in the first few months.

Contrave is also strictly contraindicated with seizure disorders (bupropion lowers the seizure threshold), opioid use (naltrexone blocks opioid receptors), and heavy alcohol consumption (increased seizure risk). If you take opioid pain medication or have a seizure history, Contrave is not an option.

GLP-1 side effects are predominantly GI: nausea (40–44%), diarrhea (30%), vomiting (24%), and constipation (24%). These typically improve during titration but can be intense during dose increases.

Cost Comparison: CurAccess Changes Things

Brand-name Contrave lists at ~$399/month, but the CurAccess program has dropped the cash-pay price to $99/month — making it one of the more affordable branded weight loss medications.

Compounded GLP-1s through telehealth start at roughly the same price point ($99–$199/month), so the cost gap that once separated these medications has narrowed significantly. The decision now comes down more to mechanism and side effect tolerance than affordability.

When to Choose Contrave

Your overeating is primarily emotional or reward-driven — you eat when stressed, bored, or anxious, and the issue isn't physical hunger. Contrave targets this specifically.

You have concurrent depression — bupropion is an effective antidepressant, making Contrave a two-for-one treatment. No GLP-1 has this dual indication.

You're needle-averse and oral semaglutide isn't accessible — Contrave is oral, taken twice daily. Some patients strongly prefer pills to weekly injections.

You want a starting point before committing to GLP-1s — some patients use Contrave as a first step in medical weight loss, graduating to GLP-1 medications if they need more than 5–6% body weight loss.

When GLP-1 Medications Are Better

You need more than modest weight loss — if your BMI is 35+ or you have significant comorbidities, Contrave's 5–6% results likely aren't sufficient. GLP-1 medications deliver the magnitude of change these patients need.

You have cardiovascular risk factors — semaglutide has proven cardiovascular protection (SELECT trial). Contrave has no cardiovascular benefit data.

You take opioid medications or have seizure history — these are absolute contraindications for Contrave but not for GLP-1s.

The Bottom Line

Contrave and GLP-1 medications aren't really competitors — they're complementary tools that address different aspects of weight management. Contrave is the better choice when psychological and reward-driven eating is the primary challenge. GLP-1 medications are superior when physical hunger, metabolic dysfunction, or large-magnitude weight loss is the goal.

For many patients, the optimal path may be starting with one and adding or switching to the other based on response. That's a conversation for you and your provider — and telehealth makes that conversation accessible from home.

Frequently Asked Questions